Income Taxes - Net Deferred Tax Assets - Valuation Allowance (Details) - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Valuation Allowance | ||
| Increase (decrease) in the valuation allowance | $ 74.8 | $ 26.8 |
| Pulmokine | ||
| Valuation Allowance | ||
| Increase (decrease) in the valuation allowance | $ (5.7) | |
| X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|